Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.5.3 to v3.5.4, indicating a newer release of the page's interface. This is a UI/system update rather than substantive changes to the study record or its data.
    Difference
    0.1%
    Check dated 2026-05-16T10:07:02.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov interface revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site tooling update rather than a change to the trial’s record data.
    Difference
    0.1%
    Check dated 2026-04-24T22:42:43.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:05.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page history now shows a new revision labeled v3.5.0, while the previous revision v3.4.3 is no longer listed.
    Difference
    0.1%
    Check dated 2026-03-19T23:54:50.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added revision entry v3.4.3 and removed v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-05T18:52:46.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    - The record history shows a new revision v3.4.2 added and v3.4.1 removed, indicating a minor update to the page’s revision history. There are no visible changes to study data or page content.
    Difference
    0.1%
    Check dated 2026-02-12T01:53:12.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.